Aug 23rd, 2023
Cell-Therapy Company Cellares Raises $255 Million
Cell therapy contract manufacturer Cellares has raised $255 million from investors to build a high-tech plant in New Jersey. CEO Fabian Gerlinghaus says the company wants to expand to Europe and Asia. He says these therapies can help cure very aggressive diseases. He speaks on "Bloomberg Technology."







